Literature DB >> 26379794

Anxiety-like behavior in Rett syndrome: characteristics and assessment by anxiety scales.

Katherine V Barnes1, Francesca R Coughlin1, Heather M O'Leary1, Natalie Bruck1, Grace A Bazin1, Emily B Beinecke1, Alexandra C Walco1, Nicole G Cantwell1, Walter E Kaufmann1.   

Abstract

BACKGROUND: Rett syndrome (RTT) is a severe neurodevelopmental disorder characterized by regression of language and motor skills, cognitive impairment, and frequent seizures. Although the diagnostic criteria focus on communication, motor impairments, and hand stereotypies, behavioral abnormalities are a prevalent and disabling component of the RTT phenotype. Among these problematic behaviors, anxiety is a prominent symptom. While the introduction of the Rett Syndrome Behavioral Questionnaire (RSBQ) represented a major advancement in the field, no systematic characterization of anxious behavior using the RSBQ or other standardized measures has been reported.
METHODS: This study examined the profiles of anxious behavior in a sample of 74 girls with RTT, with a focus on identifying the instrument with the best psychometric properties in this population. The parent-rated RSBQ, Anxiety, Depression, and Mood Scale (ADAMS), and Aberrant Behavior Checklist-Community (ABC-C), two instruments previously employed in children with neurodevelopmental disorders, were analyzed in terms of score profiles, relationship with age and clinical severity, reliability, concurrent validity, and functional implications. The latter were determined by regression analyses with the Vineland Adaptive Behavior Scales-Second Edition (Vineland-II) and the Child Health Questionnaire (CHQ), a quality of life measure validated in RTT.
RESULTS: We found that scores on anxiety subscales were intermediate in range with respect to other behavioral constructs measured by the RSBQ, ADAMS, and ABC-C. Age did not affect scores, and severity of general anxiety was inversely correlated with clinical severity. We demonstrated that the internal consistency of the anxiety-related subscales were among the highest. Test-retest and intra-rater reliability was superior for the ADAMS subscales. Convergent and discriminant validity were measured by inter-scale correlations, which showed the best profile for the social anxiety subscales. Of these, only the ADAMS Social Avoidance showed correlation with quality of life.
CONCLUSIONS: We conclude that anxiety-like behavior is a prominent component of RTT's behavioral phenotype, which affects predominantly children with less severe neurologic impairment and has functional consequences. Based on available data on standardized instruments, the ADAMS and in particular its Social Avoidance subscale has the best psychometric properties and functional correlates that make it suitable for clinical and research applications.

Entities:  

Keywords:  Anxiety; Intellectual disabilities; Problematic behavior; Rett syndrome; Social avoidance

Year:  2015        PMID: 26379794      PMCID: PMC4571061          DOI: 10.1186/s11689-015-9127-4

Source DB:  PubMed          Journal:  J Neurodev Disord        ISSN: 1866-1947            Impact factor:   4.025


  55 in total

Review 1.  Clinical manifestations and stages of Rett syndrome.

Authors:  Bengt Hagberg
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2002

Review 2.  Percentiles please: the case for expressing neuropsychological test scores and accompanying confidence limits as percentile ranks.

Authors:  John R Crawford; Paul H Garthwaite
Journal:  Clin Neuropsychol       Date:  2009-02       Impact factor: 3.535

3.  Clinical severity and quality of life in children and adolescents with Rett syndrome.

Authors:  J B Lane; H-S Lee; L W Smith; P Cheng; A K Percy; D G Glaze; J L Neul; K J Motil; J O Barrish; S A Skinner; F Annese; L McNair; J Graham; O Khwaja; K Barnes; J P Krischer
Journal:  Neurology       Date:  2011-10-19       Impact factor: 9.910

4.  Anxiety, attention problems, hyperactivity, and the Aberrant Behavior Checklist in fragile X syndrome.

Authors:  Anne Wheeler; Melissa Raspa; Carla Bann; Ellen Bishop; David Hessl; Pat Sacco; Donald B Bailey
Journal:  Am J Med Genet A       Date:  2013-11-25       Impact factor: 2.802

5.  Rett syndrome: qualitative and quantitative differentiation from autism.

Authors:  A K Percy; H Y Zoghbi; K R Lewis; J Jankovic
Journal:  J Child Neurol       Date:  1988       Impact factor: 1.987

6.  Autism spectrum disorder in fragile X syndrome: communication, social interaction, and specific behaviors.

Authors:  Walter E Kaufmann; Ranon Cortell; Alice S M Kau; Irena Bukelis; Elaine Tierney; Robert M Gray; Christiane Cox; George T Capone; Pia Stanard
Journal:  Am J Med Genet A       Date:  2004-09-01       Impact factor: 2.802

7.  Children with severe developmental disabilities and behavioral disorders have increased special healthcare needs.

Authors:  Craig H Kennedy; A Pablo Juárez; Angela Becker; Kathryn Greenslade; Mark T Harvey; Clare Sullivan; Brenna Tally
Journal:  Dev Med Child Neurol       Date:  2007-12       Impact factor: 5.449

8.  Rett syndrome: a survey of North American patients.

Authors:  M Coleman; J Brubaker; K Hunter; G Smith
Journal:  J Ment Defic Res       Date:  1988-04

9.  Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome.

Authors:  Paolo Moretti; J Adriaan Bouwknecht; Ryan Teague; Richard Paylor; Huda Y Zoghbi
Journal:  Hum Mol Genet       Date:  2004-11-17       Impact factor: 6.150

10.  Twenty years of surveillance in Rett syndrome: what does this tell us?

Authors:  Alison Anderson; Kingsley Wong; Peter Jacoby; Jenny Downs; Helen Leonard
Journal:  Orphanet J Rare Dis       Date:  2014-06-19       Impact factor: 4.123

View more
  28 in total

1.  Spoken word processing in Rett syndrome: Evidence from event-related potentials.

Authors:  Alexandra P Key; Dorita Jones; Sarika Peters
Journal:  Int J Dev Neurosci       Date:  2019-01-07       Impact factor: 2.457

2.  A Psychometric Evaluation of the Motor-Behavioral Assessment Scale for Use as an Outcome Measure in Rett Syndrome Clinical Trials.

Authors:  Melissa Raspa; Carla M Bann; Angela Gwaltney; Timothy A Benke; Cary Fu; Daniel G Glaze; Richard Haas; Peter Heydemann; Mary Jones; Walter E Kaufmann; David Lieberman; Eric Marsh; Sarika Peters; Robin Ryther; Shannon Standridge; Steven A Skinner; Alan K Percy; Jeffrey L Neul
Journal:  Am J Intellect Dev Disabil       Date:  2020-11-01

Review 3.  Hippocampal deficits in neurodevelopmental disorders.

Authors:  Yue Li; Minjie Shen; Michael E Stockton; Xinyu Zhao
Journal:  Neurobiol Learn Mem       Date:  2018-10-12       Impact factor: 2.877

Review 4.  Clinical and biological progress over 50 years in Rett syndrome.

Authors:  Helen Leonard; Stuart Cobb; Jenny Downs
Journal:  Nat Rev Neurol       Date:  2016-12-09       Impact factor: 42.937

5.  Vitamin D modulates cortical transcriptome and behavioral phenotypes in an Mecp2 heterozygous Rett syndrome mouse model.

Authors:  Mayara C Ribeiro; Jessica L MacDonald
Journal:  Neurobiol Dis       Date:  2022-01-25       Impact factor: 5.996

6.  Caregiver- and Clinician-Reported Adaptive Functioning in Rett Syndrome: a Systematic Review and Evaluation of Measurement Strategies.

Authors:  Eric S Semmel; Michelle E Fox; Sabrina D Na; Rella Kautiainen; Robert D Latzman; Tricia Z King
Journal:  Neuropsychol Rev       Date:  2019-11-20       Impact factor: 7.444

7.  Quality of life related to clinical features in patients with Rett syndrome and their parents: a systematic review.

Authors:  Silvia Corchón; Irene Carrillo-López; Omar Cauli
Journal:  Metab Brain Dis       Date:  2018-09-16       Impact factor: 3.584

Review 8.  Updated report on tools to measure outcomes of clinical trials in fragile X syndrome.

Authors:  Dejan B Budimirovic; Elizabeth Berry-Kravis; Craig A Erickson; Scott S Hall; David Hessl; Allan L Reiss; Margaret K King; Leonard Abbeduto; Walter E Kaufmann
Journal:  J Neurodev Disord       Date:  2017-06-12       Impact factor: 4.025

Review 9.  Reviewing Evidence for the Relationship of EEG Abnormalities and RTT Phenotype Paralleled by Insights from Animal Studies.

Authors:  Kirill Smirnov; Tatiana Stroganova; Sophie Molholm; Olga Sysoeva
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

10.  Phenotypic features in MECP2 duplication syndrome: Effects of age.

Authors:  Sarika U Peters; Cary Fu; Eric D Marsh; Tim A Benke; Bernard Suter; Steve A Skinner; David N Lieberman; Shannon Standridge; Mary Jones; Arthur Beisang; Timothy Feyma; Peter Heydeman; Robin Ryther; Daniel G Glaze; Alan K Percy; Jeffrey L Neul
Journal:  Am J Med Genet A       Date:  2020-11-10       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.